Scientist.com Hosts Human Biospecimen Webinar Featuring International Panel of Industry Thought Leaders

SAN DIEGO, [DATE] (BUSINESS WIRE) Scientist.com, the life science industry’s leading online marketplace for outsourced research services, announced today that it has assembled a panel of global experts on the use of human biospecimens in drug research. Set for May 14, 2018, at 9:30am EDT, the webinar will cover a variety of topics, including the sustainability of biobanks, the regulations surrounding human biospecimens and the potential benefits of pre-competitive collaboration.

“We are excited to have assembled such a distinguished panel on one of the most important topics within the life science community today—the use of human biospecimens in drug discovery,” said Matt McLoughlin, Sr. Director of Compliance at Scientist.com.  “Human biospecimens are increasingly being used in all aspects of pre-clinical and clinical research.  This is a fantastic opportunity for different stakeholders to share perspectives that will benefit the entire research community.”

The panel consists of experts in biobanking, international governance, compliance assessment and sample acquisition, including Dr. Sam Jackson of the UK-based National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3R); Erik Steinfelder, Director General of the Biobanking and Biomolecular Resources Research Infrastructure-European Research Infrastructure Consortium (BBMRI-ERIC), Matt McLoughlin, Scientist.com’s Senior Director of Compliance, and Dr. Sonja Grosskinsky of Lonza, a Switzerland-based life science solutions provider.

Go here to register for the free webinar, “Human Biological Samples: Promoting Collaboration Within the Research Community to Advance Drug Discovery.”